gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Constriction, Pathologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aita, K; Amano, Y; Kitamura, M; Kumita, S; Tachi, M; Takayama, M; Yamada, F | 1 |
Adeleine, P; Canet, E; Corot, C; Cremillieux, Y; Douek, PC; Hernandez-Hoyos, M; Marchand, B; Orkisz, M; Robert, P; Roux, JP | 1 |
2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Constriction, Pathologic
Article | Year |
---|---|
Magnetic resonance imaging of microvascular obstruction in hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Hypertrophic; Catheter Ablation; Constriction, Pathologic; Contrast Media; Echocardiography; Female; Gadolinium DTPA; Heart Septum; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Microcirculation; Middle Aged; Organometallic Compounds; Postoperative Complications | 2015 |
Standardized MR protocol for the evaluation of MRA sequences and/or contrast agents effects in high-degree arterial stenosis analysis.
Topics: Arterial Occlusive Diseases; Arteries; Constriction, Pathologic; Dose-Response Relationship, Drug; Heterocyclic Compounds; Humans; Magnetic Resonance Angiography; Models, Cardiovascular; Organometallic Compounds; Phantoms, Imaging; Quality Control; Reproducibility of Results; Sensitivity and Specificity | 2002 |